451
Participants
Start Date
January 31, 2006
Primary Completion Date
November 30, 2006
Study Completion Date
November 30, 2006
Dexlansoprazole MR
Dexlansoprazole MR 60 mg, capsules, orally, once daily for up to six months.
Dexlansoprazole MR
Dexlansoprazole MR 90 mg, capsules, orally, once daily for up to six months.
Placebo
Dexlansoprazole placebo-matching capsules, orally, once daily for up to six months.
Anniston
Hueytown
Huntsville
Tallassee
Tuscaloosa
Tucson
Little Rock
North Little Rock
Azusa
Carmichael
Cypress
Fresno
Los Angeles
Modesto
Newport Beach
Oakland
Orange
San Diego
Santa Maria
Littleton
Longmont
Wheat Ridge
Bristol
Newark
Fort Myers
Miami
Naples
New Smyrna Beach
Ocala
Pembroke Pines
Port Orange
Sarasota
St. Petersburg
Zephyrhills
Atlanta
Champaign
Moline
North Chicago
Oak Forest
Springfield
Evansville
Indianapolis
Newburgh
Davenport
Kansas City
Wichita
Lexington
Louisville
Baton Rouge
Chevy Chase
Prince Frederick
Jackson
Jefferson City
Kansas City
St Louis
Missoula
Egg Harbor
Albuquerque
Chapel Hill
Charlotte
Greensboro
High Point
Raleigh
Wilmington
Winston-Salem
Bismarck
Akron
Columbus
Dayton
Mogadore
Oklahoma City
Medford
Portland
Philadelphia
Warwick
Anderson
Mt. Pleasant
Sioux Falls
Chattanooga
Germantown
Jackson
Johnson City
Kingsport
Amarillo
Conroe
Dallas
Fort Worth
Houston
Odessa
Pharr
Seguin
Temple
Salt Lake City
Charlottesville
Norfolk
Richmond
Bellevue
Lakewood
Tacoma
Milwaukee
Lead Sponsor
Takeda
INDUSTRY